QA: Xenetic Biosciences Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001534525_2023_Xenetic_Biosciences_Inc.pdf

Logs

Graph

Absolute values for 0001534525, Xenetic Biosciences Inc.

  xvar xval
0 AssetsCurrent 13,653,359
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 1,066,931
4 LiabilitiesCurrent 1,073,156
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 3,653,999
9 ResearchAndDevelopmentExpense 4,770,834
10 remainder_Expenses 0
11 remainder_Revenues 1,706,925
12 remainder_NetIncome 165,555
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 14,720,290
1 Liabilities 1,073,156
2 Expenses 8,424,833
3 Revenues 1,706,925
4 StockholdersEquity 13,647,134
5 NetIncome -6,552,353
6 ComprehensiveNetIncome -6,552,353
7 BaseVar 13,045,380
8 EconomicCapitalRatio 2.14

Edgar->Model Mapping

Feature Distribution

Change over Time